Ex-Pfizer Worker Seeks No Time For Paxlovid Insider Trading

By Emilie Ruscoe · July 15, 2024, 10:51 PM EDT

A former Pfizer employee argued that he shouldn't go to prison after a Manhattan federal jury convicted him of insider trading over clinical trial results for the drug Paxlovid, pointing out...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Memorandum

Case Information

Case Title

Case Number

Court

New York Southern

Nature of Suit

Date Filed

June 28, 2023

Recent Articles By Emilie

November 05, 2024
Bright Health Beats Investor Suit Over COVID-19 Costs
October 30, 2024
LA Times Owner Faces Investor Suit Over Drug Co.'s Woes
October 28, 2024
Moderna Brass Hit With Investor Suit Over RSV Shot Claims
October 22, 2024
Pharma Co. Verrica Faces Derivative Suit Over FDA Inspection
October 16, 2024
Pharma Co. Contractor Settles SEC Insider Trading Claim
September 24, 2024
Biotech RenovaCare Investors Seek OK Of $2M Deal
September 03, 2024
Teva Investors Get Go-Ahead To Resume Kickbacks Class Suit
August 02, 2024
Health Tech Co. Beats Investor Data Platform Fraud Claim
May 20, 2024
Teladoc Faces Suit Over Mental Health Platform's Losses
May 14, 2024
Vein Tech Maker Faces Investor Suit Over DOJ Kickback Probe